Opening Keynotes, • 9/25/25 Opening Keynote: The Future of Rare Disease Trials Next Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Reducing Patient Burden in Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
Opening Keynotes, • 9/25/25 Opening Keynote: The Future of Rare Disease Trials Next Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Reducing Patient Burden in Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
